Literature DB >> 32404253

Promoter region mutations of the telomerase reverse transcriptase (TERT) gene in head and neck squamous cell carcinoma.

Ismail Yilmaz1, Bulent Evren Erkul2, Sule Ozturk Sari3, Gizem Issin4, Ersin Tural5, Neslihan Terzi Kaya Terzi6, Huseyin Karatay3, Mehmet Celik7, Murat Ulusan7, Bilge Bilgic3.   

Abstract

OBJECTIVE: The aim of the present study was to assess the prevalence of TERT promoter region mutations in tumor samples of patients with squamous cell carcinoma at different sites of the head and neck region and correlate it with patients' clinicopathologic data. STUDY
DESIGN: Mutations in promoter region of the TERT gene were analyzed with polymerase chain reaction-based direct sequencing method using formalin-fixed, paraffin-embedded tumor samples of 189 HNSCCs. TERT promoter region mutations were assessed in terms of age, gender, location, smoking, alcohol consumption, and overall survival.
RESULTS: TERT promoter region mutations were detected in the oral cavity (75%); larynx (8.4%), hypopharynx (16.6%), and oropharynx (0%). TERT promoter region mutations are associated with younger age and female gender and have a reverse relationship with smoking and alcohol consumption.
CONCLUSIONS: We found statistically significant higher rates of TERT promoter region mutations in tumor samples of patients with squamous cell carcinoma in the oral cavity compared with other locations in the head and neck region.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32404253     DOI: 10.1016/j.oooo.2020.02.015

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  6 in total

Review 1.  Human TERT promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis.

Authors:  Md Abdul Aziz; Sarah Jafrin; Mohammad Safiqul Islam
Journal:  Hum Cell       Date:  2021-03-20       Impact factor: 4.174

2.  Analysis of Mutational Profile of Hypopharyngeal and Laryngeal Head and Neck Squamous Cell Carcinomas Identifies KMT2C as a Potential Tumor Suppressor.

Authors:  Marcin M Machnicki; Anna Rzepakowska; Joanna I Janowska; Monika Pepek; Alicja Krop; Katarzyna Pruszczyk; Piotr Stawinski; Malgorzata Rydzanicz; Jakub Grzybowski; Barbara Gornicka; Maciej Wnuk; Rafal Ploski; Ewa Osuch-Wojcikiewicz; Tomasz Stoklosa
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

3.  TERT Promoter Mutations and rs2853669 Polymorphism: Useful Markers for Clinical Outcome Stratification of Patients With Oral Cavity Squamous Cell Carcinoma.

Authors:  Silvia Giunco; Paolo Boscolo-Rizzo; Enrica Rampazzo; Giancarlo Tirelli; Lara Alessandrini; Roberto Di Carlo; Marco Rossi; Piero Nicolai; Anna Menegaldo; Valentina Carraro; Margherita Tofanelli; Luigia Bandolin; Giacomo Spinato; Enzo Emanuelli; Monica Mantovani; Marco Stellin; Rossana Bussani; Angelo Paolo Dei Tos; Maria Guido; Marzia Morello; Jonathan Fussey; Giovanni Esposito; Jerry Polesel; Anita De Rossi
Journal:  Front Oncol       Date:  2021-11-10       Impact factor: 6.244

Review 4.  Prognostic and Clinicopathological Significance of Telomerase Reverse Transcriptase Upregulation in Oral Cancer: A Systematic Review and Meta-Analysis.

Authors:  Miguel Ángel González-Moles; Eloísa Moya-González; Alberto García-Ferrera; Paola Nieto-Casado; Pablo Ramos-García
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

Review 5.  The Drivers, Mechanisms, and Consequences of Genome Instability in HPV-Driven Cancers.

Authors:  Vanessa L Porter; Marco A Marra
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

Review 6.  Breast cancer: Muscarinic receptors as new targets for tumor therapy.

Authors:  Alejandro Español; Agustina Salem; Yamila Sanchez; María Elena Sales
Journal:  World J Clin Oncol       Date:  2021-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.